Oncology Nursing News®

Oncology Nursing Articles

Nivolumab Extends Survival in Advanced or Recurrent Esophageal Cancer

Nivolumab Extends Survival in Advanced or Recurrent Esophageal Cancer

BY GINA COLUMBUS

FDA Warns of Safety Concerns With Paclitaxel-Coated Devices

BY GINA COLUMBUS

FDA Accepts sBLA for Frontline Atezolizumab Plus Carboplatin/Nab-Paclitaxel in Nonsquamous NSCLC

FDA Accepts sBLA for Frontline Atezolizumab Plus Carboplatin/Nab-Paclitaxel in Nonsquamous NSCLC

BY GINA COLUMBUS

Targeted Therapies Extend OS in Stage IV ALK+ Lung Cancer Patients

Targeted Therapies Extend OS in Stage IV ALK+ Lung Cancer Patients

BY KATIE KOSKO

US Cancer Death Rate Drops 27% Over 25 Years

US Cancer Death Rate Drops 27% Over 25 Years

BY DANIELLE TERNYILA

FDA Grants Breakthrough Designation to Zanubrutinib for Mantle Cell Lymphoma

FDA Grants Breakthrough Designation to Zanubrutinib for Mantle Cell Lymphoma

BY GINA COLUMBUS

FDA Approves Cabozantinib for Advanced Liver Cancer

FDA Approves Cabozantinib for Advanced Liver Cancer

BY JASON M. BRODERICK

UGN-101 Improves Complete Response Rates in Urothelial Cancer Treatment

UGN-101 Improves Complete Response Rates in Urothelial Cancer Treatment

BY GINA COLUMBUS

Does Gender Influence Adherence?

Does Gender Influence Adherence?

BY DEBORAH A. BOYLE, MSN, RN, AOCNS, FAAN

HPV Subtypes Correlated with Higher Risk for High-Grade Cervical Cancer

HPV Subtypes Correlated with Higher Risk for High-Grade Cervical Cancer

BY CAROLINE SEYMOUR

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.